These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20676140)

  • 1. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
    Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
    Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
    Ma O; Cai WW; Zender L; Dayaram T; Shen J; Herron AJ; Lowe SW; Man TK; Lau CC; Donehower LA
    Cancer Res; 2009 Mar; 69(6):2559-67. PubMed ID: 19276372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
    Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
    Oncogene; 2021 Mar; 40(9):1754. PubMed ID: 33510357
    [No Abstract]   [Full Text] [Related]  

  • 4. cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.
    Lau R; Niu MY; Pratt MA
    Cell Cycle; 2012 Nov; 11(21):4009-19. PubMed ID: 23032264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.
    Jiang Z; Deng T; Jones R; Li H; Herschkowitz JI; Liu JC; Weigman VJ; Tsao MS; Lane TF; Perou CM; Zacksenhaus E
    J Clin Invest; 2010 Sep; 120(9):3296-309. PubMed ID: 20679727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas.
    Hélias-Rodzewicz Z; Pérot G; Chibon F; Ferreira C; Lagarde P; Terrier P; Coindre JM; Aurias A
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1161-71. PubMed ID: 20842732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
    Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
    Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.
    Lorenzetto E; Brenca M; Boeri M; Verri C; Piccinin E; Gasparini P; Facchinetti F; Rossi S; Salvatore G; Massimino M; Sozzi G; Maestro R; Modena P
    Oncotarget; 2014 May; 5(9):2608-21. PubMed ID: 24810989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.
    Jones RA; Moorehead RA
    Genes Chromosomes Cancer; 2019 Jun; 58(6):381-391. PubMed ID: 30597648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours.
    Tao L; Xiang D; Xie Y; Bronson RT; Li Z
    Nat Commun; 2017 Feb; 8():14431. PubMed ID: 28194015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.
    McClendon AK; Dean JL; Ertel A; Fu Z; Rivadeneira DB; Reed CA; Bourgo RJ; Witkiewicz A; Addya S; Mayhew CN; Grimes HL; Fortina P; Knudsen ES
    Gastroenterology; 2011 Oct; 141(4):1439-50. PubMed ID: 21704587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurring Amplification at 11q22.1-q22.2 Locus Plays an Important Role in Lymph Node Metastasis and Radioresistance in OSCC.
    Bhosale PG; Pandey M; Cristea S; Shah M; Patil A; Beerenwinkel N; Schäffer AA; Mahimkar MB
    Sci Rep; 2017 Nov; 7(1):16051. PubMed ID: 29167558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation.
    Petrovic V; Malin D; Cryns VL
    Breast Cancer Res Treat; 2013 Apr; 138(2):415-25. PubMed ID: 23471649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.
    Zender L; Spector MS; Xue W; Flemming P; Cordon-Cardo C; Silke J; Fan ST; Luk JM; Wigler M; Hannon GJ; Mu D; Lucito R; Powers S; Lowe SW
    Cell; 2006 Jun; 125(7):1253-67. PubMed ID: 16814713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
    Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
    Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.
    Jones RA; Robinson TJ; Liu JC; Shrestha M; Voisin V; Ju Y; Chung PE; Pellecchia G; Fell VL; Bae S; Muthuswamy L; Datti A; Egan SE; Jiang Z; Leone G; Bader GD; Schimmer A; Zacksenhaus E
    J Clin Invest; 2016 Oct; 126(10):3739-3757. PubMed ID: 27571409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.
    Matondo RB; Toussaint MJ; Govaert KM; van Vuuren LD; Nantasanti S; Nijkamp MW; Pandit SK; Tooten PC; Koster MH; Holleman K; Schot A; Gu G; Spee B; Roskams T; Rinkes IB; Schotanus B; Kranenburg O; de Bruin A
    Oncotarget; 2016 Aug; 7(34):54662-54675. PubMed ID: 27323406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
    Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
    Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.
    Akeno N; Miller AL; Ma X; Wikenheiser-Brokamp KA
    Oncogene; 2015 Jan; 34(5):589-99. PubMed ID: 24469052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.